Dr. Conrad Winters has been appointed director of drug product development at Hovione. Dr. Winters was previously with Merck in the U.S. and Canada and most recently with Xenon Pharmaceuticals, where he served as senior director of Compound Properties Group.   “We are very pleased to welcome Dr. Winters to Hovione. His experience in particle engineering, solubilization, drug product development, scale up and commercialization will enable us to solve our customers’ most challenging pr...